The short version of REV-ERB fits in a sentence. The long version — which is the one that helps — is below.
Reviewed 2025-10-05. Anything still debated is marked as such rather than presented as settled.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. These receptors help regulate circadian rhythms, lipid metabolism, and inflammatory gene expression. In cell and animal experiments, SR9009 alters transcription of clock-controlled genes and metabolic pathways. The compound is not a hormone and does not resemble classical steroid structures. Its activity depends on binding to the ligand-binding domain of REV-ERB, where it can modify corepressor recruitment.
Research interest in SR9009 grew from studies of circadian biology and metabolic disease. Preclinical reports describe effects on exercise capacity, muscle metabolism, and blood lipid levels in rodents, but these findings come from controlled laboratory settings. The compound has low oral bioavailability in animals, which limits systemic exposure after swallowing. Investigators often use injected routes in experiments to achieve measurable plasma concentrations. Human clinical data are sparse, no approved therapeutic product exists, and whether animal effects translate to humans remains an open question.
Stability depends on physical form, temperature, light exposure, and solvent. Solid SR9009 is generally stored cold and dry, with protection from light to limit degradation. Dimethyl sulfoxide stocks are common for laboratory work, but repeated freeze-thaw cycles can reduce compound integrity. Aqueous solutions may be less stable than organic stocks, and the ethyl ester in the structure can be susceptible to hydrolysis under certain conditions. Researchers typically validate storage conditions and recheck purity before quantitative experiments, especially when using archived material.
Regulatory treatment of SR9009 varies by country and region. It is not approved as a pharmaceutical, and several jurisdictions restrict its sale for human consumption. Some authorities classify it as a research chemical, a prescription-only substance, or a prohibited performance-enhancing agent in sport. Purchasers may encounter certificates of analysis, but these documents do not guarantee identity, purity, or legality. In research settings, institutional safety reviews and controlled procurement help ensure that materials are handled under appropriate oversight. The absence of harmonized rules means that legal status can change and requires verification.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic REV-ERB agonist | Binds REV-ERBα and REV-ERBβ in preclinical models |
| Molecular formula | C20H24ClN3O4S | Reported for the parent compound |
| CAS Registry Number | 1379686-30-2 | Common identifier in chemical databases |
| Appearance | Off-white to pale yellow solid | Typical research chemical solid |
| Solubility | Soluble in DMSO and ethanol; low in water | Class: small organic molecule |
Because REV-ERB receptors are core clock components, SR9009 has been examined for effects on daily rhythms as well as metabolism. Research has explored whether the compound can shift or reinforce circadian gene expression in tissues such as liver and muscle. Some studies report improved metabolic markers in obese or diabetic mice, while others show context-dependent responses. Questions remain about which effects are direct, which are secondary to timing, and how they might differ across species.
SR9009 is a synthetic small molecule studied as an agonist of REV-ERB nuclear receptors. REV-ERB alpha and REV-ERB beta help regulate circadian rhythms and metabolic gene expression. In laboratory research, SR9009 has been used to probe how these receptors affect skeletal muscle, liver, and adipose tissue. The compound was identified in academic drug-discovery work and is often described in scientific literature by its chemical name and research code. It is not an approved medicine, and human clinical data remain limited or absent.
SR9009 binds REV-ERB receptors and alters their repressive activity on target genes. This action can change transcription of genes involved in lipid handling, glucose metabolism, and mitochondrial function. In rodent studies, treated animals have shown changes in muscle oxidative capacity and exercise performance, though effects vary by dose, duration, and model. The precise molecular steps connecting receptor binding to whole-body outcomes are still an active area of investigation. Findings in animals do not automatically translate to humans.
REV-ERB proteins typically suppress gene expression by recruiting corepressor complexes to DNA response elements. SR9009 binds these receptors and strengthens that repressive action in cell-based assays. Studies in rodents have reported changes in lipid handling, mitochondrial function, and exercise capacity after treatment. Such findings are often cited as evidence for metabolic effects, but species differences and limited pharmacokinetic data make direct translation to humans uncertain. Researchers continue to examine which effects are robust and which depend on specific experimental conditions.
SR9009 is frequently discussed alongside other REV-ERB ligands, including synthetic agonists and natural heme-related molecules. Its selectivity for REV-ERB over related nuclear receptors has been measured in binding and reporter assays, though off-target activity at higher concentrations is possible. The compound is prohibited in sport by the World Anti-Doping Agency, and it is not approved for any medical use in major jurisdictions. Products sold online may be labeled as research chemicals, and their identity and purity are not guaranteed by regulatory review.
16 December Sunak travels to Italy to attend a right-wing rally in Rome, where he discusses his immigration policy and calls for changes to global refugee rules. Defence Secretary Grant Shapps confirms that the British destroyer HMS Diamond has shot down a suspected attack drone in the Red Sea, the first time the Royal Navy has shot down an aerial object in anger since 1991. Greater Manchester Police confirm that teenager Alex Batty has returned to the UK. 17 December The UK's first spaceport for vertical rocket launches is granted planning approval by the Civil Aviation Authority. Full orbital launches from the site, on the remote Scottish island of Unst, are expected to commence from 2025. Michelle Mone says that, under specific circumstances, she could benefit from some of the profits made by personal protective equipment sold to the UK government during the COVID-19 pandemic by a company run by her husband, Doug Barrowman. Ian Wright announces that he will step down as a pundit from Match of the Day at the end of the premier league season. 18 December Fezolinetant, a non-hormonal drug used to treat menopause-related hot flushes and night sweats, is approved for use in the UK. Chief Veterinary Officer Christine Middlemiss confirms that 4,000 American XL bully dog owners have applied for exemption from a forthcoming ban on the breed, but warns there could be more XL bullies living in the UK. A dress worn by Diana, Princess of Wales in 1985 sells at an auction for £904,262 ($1,148,080), eleven times its estimated price.
Despite never having attended college – or any formal schooling beyond high school – Rathbun had authored more than 80 scientific publications, described over 674 new species of crustacean, and developed a system for crustacean-related records at the Smithsonian Museum. 1917: Dutch biologist and phytopathologist Johanna Westerdijk became the first female university professor in the Netherlands. She was appointed an extraordinary professor of phytopathology at the University of Utrecht. 1918: German physicist and mathematician Emmy Noether created Noether's theorem explaining the connection between symmetry and conservation laws. 1919: Dutch biologist and geneticist Jantina Tammes became the university professor in the Netherlands. She was appointed an extraordinary professor of variability and heredity at the University of Groningen. She became the first person in the Netherlands to occupy a chair in genetic. Moreover, she became the second female professor in the country, and the first one at the University of Groningen. She held this position until 1937, when she resigned at the age of sixty-six. 1919: Chilean engineer Justicia Espada Acuña graduates from Universidad de Chile, becoming the first woman with degree in civil engineering in South America 1919: Kathleen Maisey Curtis became the first New Zealand woman to earn a Doctorate of Science degree (DSc), completing her thesis on Synchytrium endobioticum (potato wart disease) at the Imperial College of Science and Technology.
== History == President Dr. Arif Alvi granted approval for the reconstitution of the NEC on 8 June 2022, in accordance with the guidelines outlined in Article 156 of the Constitution. The NEC consists of a total of 13 members, led by the Prime Minister of Pakistan, who serves as the chairman. In addition to the chief ministers from all provinces, the council includes various federal ministers and nominated representatives from different political parties and provinces.
== Prognosis == Kwashiorkor is associated with a high risk of mortality and long-term complications. Treatment under the guidelines of the World Health Organization has proven to reduce this mortality risk and affected children tend to recover faster than children with other severe malnutrition diseases. However, physical and intellectual capabilities are not fully restored. Growth stunting and chronic disruption of microbiota are commonly observed after recovery. A high risk of death is identified by a brachial perimeter < 11 cm or by a weight-for-age threshold < −3 z-scores below the median of the WHO child growth standards. In practice, malnourished children with edema are suffering from potentially life-threatening severe malnutrition.
Sources: en.wikipedia.org
The broadcast pattern covered an area of about 100 degrees in a roughly fan-shaped area, with a smaller side lobe to the rear, courtesy of the reflectors, and much smaller ones to the sides. When the signal reflected off the ground it underwent a ½ wavelength phase-change, which caused it to interfere with the direct signal. The result was a series of vertically stacked lobes about 5 degrees wide from 1 degree off the ground to the vertical. The system was later expanded by adding another set of four additional antennas closer to the ground, wired in a similar fashion. The receiver consisted of an Adcock array consisting of four 240 foot (73 m) tall wooden towers arranged at the corners of a square. Each tower had three sets (originally two) of receiver antennas, one at 45, 95 and 215 feet off the ground. The mean height of the transmitter stack was 215 feet, which is why the topmost antenna was positioned at the same altitude in order to produce a reception pattern that was identical to the transmission. A set of motor-driven mechanical switches allowed the operator to select which antenna was active. The output of the selected antenna on each of the four towers was sent to a single radiogoniometer system (not Watt's own huff-duff solution). By connecting the antennas together in X-Y pairs the horizontal bearing could be measured, while connecting together the upper and lower antennas allowed the same goniometer to be used to measure the vertical angle. Two physical layout plans were used, either 'East Coast' or 'West Coast'.
On 20 January 2001 the Indian Space Research Organisation (ISRO) conducted a balloon flight from Hyderabad, India to collect stratospheric dust from a height of 41 km (135,000 ft) with a view to testing for the presence of living cells. The collaborators on this project included a team of UK scientists led by Wickramasinghe. In a paper presented at a SPIE conference in San Diego in 2002 the detection of evidence for viable microorganisms from 41 km above the Earth's surface was presented. However, the experiment did not present evidence as to whether the findings are incoming microbes from space rather than microbes carried up to 41 km from the surface of the Earth. In 2005 the ISRO group carried out a second stratospheric sampling experiment from 41 km altitude and reported the isolation of three new species of bacteria including one that they named Janibacter hoylei sp.nov. in honour of Fred Hoyle. However, these facts do not prove that bacteria on Earth originated in the cosmic environment. Samplings of the stratosphere have also been carried out by Yang et al. (2005, 2009). During the experiment strains of highly radiation-resistant Deinococcus bacterium were detected at heights up to 35 km. Nevertheless, these authors have abstained from linking these discoveries to panspermia. Wickramasinghe was also involved in coordinating analyses of the red rain in Kerala in collaborations with Godfrey Louis.
Other clinicians described a cluster of near‑fatal collapses between March and June 2016, including the deaths of two triplets on consecutive days. The prosecution alleged that two infants, Baby F and Baby L, had been deliberately poisoned with insulin, citing blood test results identified during the police investigation. Their lead expert witness described this as key evidence, though their interpretation has since been questioned by some specialists. The prosecution also argued that Baby M, the twin of Baby L, collapsed after air was injected into his bloodstream. Letby had volunteered for the shift on which Baby L collapsed, despite not being scheduled for night duty. Several consultants told the court they had previously raised concerns about Letby but were discouraged by hospital managers. One doctor recalled Letby making a remark shortly before an infant's death that he interpreted as inappropriate. The prosecution also presented a shift‑pattern chart showing Letby on duty for 25 incidents, supported by swipe‑card data. The chart has since been criticised by some statisticians as misleading. After Letby was removed from clinical duties, the unit's admission criteria were tightened to stop receiving the sickest babies, and more consultants were hired; the unexpected deaths ceased. The prosecution further alleged that Letby altered times on patient records; she denied this, saying any discrepancies were errors.
β1Rs preferentially bind epinephrine, along with norepinephrine to a lesser extent and mediates some of their cellular effects in cardiac myocytes such as increased positive inotropy and lusitropy. β-blockers exert their cardioprotective effects through decreasing oxygen demand in cardiac myocytes; this is accomplished via decreasing the force of contraction during systole (negative inotropy) and decreasing the rate of relaxation during diastole (negative lusitropy), thus reducing myocardial energy demand which is useful in treating cardiovascular disorders accompanied by inadequate myocardial oxygen supply. Alpha blockers, which counter the effects of noradrenaline on alpha-adrenergic receptors, are occasionally used to treat hypertension and psychiatric conditions. Alpha-2 agonists often have a sedating and antihypertensive effect and are commonly used as anesthesia enhancers in surgery, as well as in treatment of drug or alcohol dependence. For reasons that are still unclear, some Alpha-2 agonists, such as guanfacine, have also been shown to be effective in the treatment of anxiety disorders and ADHD. Many important psychiatric drugs exert strong effects on noradrenaline systems in the brain, resulting in effects that may be helpful or harmful.
According to Rebecca Herzig, the modern-day notion of body hair being unwomanly can be traced back to Charles Darwin's book first published in 1871 "The Descent of Man and Selection in Relation to Sex". Darwin's theory of natural selection associated body hair with "primitive ancestry and an atavistic return to earlier less developed forms", writes Herzig, a professor of gender and sexuality studies at Bates College in Maine. Darwin also suggests having less body hair was an indication of being more evolved and sexually attractive. As Darwin's ideas polarized, other 19th century medical and scientific experts started to link hairiness to "sexual inversion, disease pathology, lunacy, and criminal violence". Those connotations were mostly applied to women's and not men's body hair. By the early 20th century, the upper- and middle-class white America increasingly saw smooth skin as a marker of femininity, and female body hair as repulsive, with hair removal giving "a way to separate oneself from cruder people, lower class and immigrant". Harper's Bazaar, in 1915, was the first women's fashion magazine to run a campaign devoted to the removal of underarm hair as "a necessity". Shortly after, Gillette launched the first safety razor marketed specifically for women—the "Milady Décolleté Gillette", one that solves "...an embarrassing personal problem" and keeps the underarm "...white and smooth".
Sources: en.wikipedia.org
SR9009 is a synthetic small molecule studied as an agonist of the REV-ERB nuclear receptors. It is not an approved medicine, and its effects in humans are not well characterized.
No. It is a synthetic ligand that binds nuclear receptors, not a steroid or peptide hormone. Its activity depends on receptor binding rather than endocrine secretion.
Clinical evidence is limited. Most published data come from cell and animal experiments. Human safety and efficacy remain uncertain.
The most common approach is liquid chromatography-tandem mass spectrometry, often after extraction from blood, urine, or tissue. Ultraviolet detection and nuclear magnetic resonance spectroscopy are used mainly for reference material characterization. Isotope-labeled internal standards improve accuracy.